| Number (%) |
41,410 |
951 (2.30) |
4,194 (10.13) |
11,132 (26.88) |
13,731 (33.16) |
7,611 (18.38) |
1,741 (4.20) |
2,050 (4.95) |
| 9 year Mortality (%) |
17,519 (42.31) |
576 (60.57) |
1,758 (41.92) |
4,038 (36.27) |
5,384 (39.21) |
3,500 (45.99) |
844 (48.48) |
1,419 (69.22) |
| 5 year Mortality (%) |
10,202 (24.64) |
475 (49.95) |
1,012 (24.13) |
2,345 (21.07) |
3,073 (22.38) |
1,931 (25.37) |
491 (28.20) |
875 (42.68) |
| Age (SD) |
69.48 (8.53) |
63.03 (10.48) |
66.99 (9.40) |
68.70 (8.83) |
70.25 (8.12) |
71.36 (7.11) |
68.25 (9.06) |
70.77 (7.81) |
| Race |
|
|
|
|
|
|
|
|
| White (%) |
35,481 (85.68) |
674 (70.87) |
3,531 (84.19) |
9,656 (86.74) |
11,939 (86.95) |
6,603 (86.76) |
1,401 (80.47) |
1,677 (81.80) |
| Black (%) |
5,205 (12.57) |
265 (27.87) |
578 (13.78) |
1,261 (11.33) |
1,562 (11.38) |
893 (11.73) |
310 (17.81) |
336 (16.39) |
| Other (%) |
724 (1.75) |
12 (1.26) |
85 (2.03) |
215 (1.93) |
230 (1.68) |
115 (1.51) |
30 (1.72) |
37 (1.80) |
| Male Gender (%) |
39,293 (94.89) |
799 (84.02) |
3,927 (93.63) |
10,564 (94.90) |
13,055 (95.08) |
7,343 (96.48) |
1,615 (92.76) |
1,990 (97.07) |
| Cerebrovascular Disease (%) |
400 (0.97) |
13 (1.37) |
34 (0.81) |
75 (0.67) |
131 (0.95) |
84 (1.10) |
30 (1.72) |
33 (1.61) |
| Cardiovascular Disease (%) |
19,772 (47.75) |
429 (45.11) |
1,832 (43.68) |
4,909 (44.10) |
6,367 (46.37) |
4,103 (53.91) |
874 (50.20) |
1,258 (61.37) |
| Dementia (%) |
2,212 (5.34) |
83 (8.73) |
235 (5.60) |
556 (4.99) |
700 (5.10) |
367 (4.82) |
122 (7.01) |
149 (7.27) |
| Diabetes Mellitus (%) |
14,639 (35.35) |
376 (39.54) |
1,438 (34.29) |
3,412 (30.65) |
4,343 (31.63) |
3,178 (41.76) |
812 (46.64) |
1,080 (52.68) |
| Hepatitis C (%) |
816 (1.97) |
58 (6.10) |
121 (2.89) |
204 (1.83) |
206 (1.50) |
116 (1.52) |
58 (3.33) |
53 (2.59) |
| HIV (%) |
2,991 (7.22) |
128 (13.46) |
376 (8.97) |
789 (7.09) |
863 (6.29) |
490 (6.44) |
185 (10.63) |
160 (7.80) |
| Hypertension (%) |
35,073 (84.70) |
769 (80.86) |
3,451 (82.28) |
9,094 (81.69) |
11,501 (83.76) |
6,857 (90.09) |
1,511 (86.79) |
1,890 (92.20) |
| Hyperlipidemia (%) |
29,554 (71.37) |
602 (63.30) |
2,847 (67.88) |
7,939 (71.32) |
9,828 (71.58) |
5,588 (73.42) |
1,214 (69.73) |
1,536 (74.93) |
| Chronic Lung Disease (%) |
11,283 (27.25) |
378 (39.75) |
1,285 (30.64) |
2,904 (26.09) |
3,463 (25.22) |
2,084 (27.38) |
545 (31.30) |
624 (30.44) |
| Peripheral Artery Disease (%) |
2,166 (5.23) |
86 (9.04) |
210 (5.01) |
466 (4.19) |
617 (4.49) |
168 (6.15) |
129 (7.41) |
190 (9.27) |
| Average eGFR slope before T0 ml/min/1.73m2/year (SD) |
4.01 (3.36) |
8.19 (7.88) |
5.01 (3.76) |
4.06 (2.96) |
3.59 (2.64) |
3.39 (2.84) |
6.01 (4.93) |
3.17 (2.86) |
| Average initial eGFR in ml/min/1.73m2 (SD) |
53.18 (4.30) |
54.88 (3.96) |
55.00 (3.88) |
54.41 (3.96) |
52.59 (4.17) |
51.44 (4.21) |
55.05 (3.85) |
50.83 (4.17) |
| Average T0 eGFR in ml/min/1.73m2 (SD) |
64.18 (10.29) |
88.52 (13.73) |
72.39 (9.24) |
66.29 (7.08) |
61.23 (6.49) |
58.31 (7.59) |
78.27 (11.52) |
54.31 (10.44) |
| Median duration between initial and T0 eGFR in years (IQR) |
3.51 (2.43, 4.26) |
4.01 (3.16, 4.50) |
3.72 (2.74, 4.36) |
3.51 (2.49, 4.23) |
3.36 (2.28, 4.20) |
3.44 (2.32, 4.24) |
3.71 (2.71, 4.36) |
3.71 (2.53, 4.38) |
| Median number of eGFR measure before T0 (IQR) |
8 (5, 12) |
12 (7, 18) |
9 (6, 13) |
8 (5, 11) |
7 (5, 11) |
8 (5, 13) |
9 (6, 14) |
10 (6, 16) |
| Median number of eGFR measure after T0 (IQR) |
13 (7, 21) |
12 (5, 22) |
14 (7, 22) |
13 (7, 21) |
13 (7, 21) |
14 (7, 22) |
16 (9, 26) |
12 (6, 24) |
| Average eGFR change after T0 in ml/min/1.73m2/year (SD) |
-1.82 (7.20) |
0.31 (12.18) |
0.82 (6.66) |
-0.36 (6.55) |
-1.66 (5.85) |
-3.39 (6.60) |
-6.19 (8.73) |
-7.53 (10.92) |
| Average Annual percentage eGFR change after T0 (SD) |
-2.63% (11.36%) |
1.25% (14.49%) |
1.56% (9.54%) |
-0.15% (9.95%) |
-2.36% (9.41%) |
-5.45% (11.21%) |
-7.59% (9.97%) |
-13.10% (20.02%) |
| Weight |
|
|
|
|
|
|
|
|
| Number |
38997 |
779 |
4,071 |
10,719 |
12,941 |
7,007 |
1,592 |
1,888 |
| Average Annual change lb/year (SD) |
-1.20 (7.01) |
-2.99 (8.85) |
-1.56 (7.43) |
-1.00 (7.55) |
-1.03 (5.96) |
-1.15 (6.35) |
-2.30 (8.25) |
-1.18 (9.30) |
| Median Annual percentage change (IQR) |
-0.47% (-1.76%, 0.72%) |
-1.25% (-3.20%, 0.52%) |
-0.58% (-2.02%, 0.73%) |
-0.41% (-1.66%, 0.75%) |
-0.44% (-1.65%, 0.73%) |
-0.42% (-1.70%, 0.71%) |
-0.77% (-2.27%, 0.38%) |
-0.54% (-2.11%, 0.78%) |
| Micro albumin / Creatinine Ratio |
|
|
|
|
|
|
|
|
| Number |
12,792 |
196 |
1,305 |
3,361 |
4,046 |
2,600 |
602 |
682 |
| Normal (%) |
7,716 (60.32) |
124 (63.27) |
882 (67.59) |
2,291 (68.16) |
2,521 (62.31) |
1,344 (51.69) |
312 (51.83) |
242 (35.48) |
| Mild (%) |
4,455 (34.83) |
69 (35.20) |
384 (29.43) |
986 (29.34) |
1,395 (34.48) |
1,060 (40.77) |
243 (40.37) |
318 (46.63) |
| Severe (%) |
621 (4.85) |
3 (1.53) |
39 (2.99) |
84 (2.50) |
130 (3.21) |
196 (7.54) |
47 (7.81) |
122 (17.89) |
